Second Irregularity In NSABP Data Found; Fisher Takes Leave As Group’s Chairman
In Brief: Ross Retires From Bristol-Myers, Forms Own Consulting Service; Obey Wins Key Post
NCI Promises Strong Monitoring Process Visco Calls For Independent Review; Rep. Dingell Plans Hearing April 13
Biotech Organization Endorses Measures On Orphan Drug Act
Salick Signs contract for Fixed-Price Oncology Services
DCE Advisors OK RFAs In Occupational Cancer, H. Pylori
Trending Stories
- Trump administration seeks to slash NIH by roughly 40% as 27 institutes and centers are whittled down to eight
NCI to remain intact, but its finances are uncertain; FDA is spared big cuts - DOD cancer research programs face 57% funding cut in year-long continuing resolution
Pancreatic, lung, kidney cancer research programs eliminated - Banished from the institute he founded, separated from his lab materials, Tom Curran sues Children’s Mercy
Whistleblower lawsuit alleges wrongful firing - Only half of adolescents and young adults with cancer get fertility counseling before treatment
Oncofertility consult is an oft-overlooked standard of care - Tom Sellers steps down as director of OHSU Knight, replaced by Lisa Coussens
Shivaani Kummar recently named interim CEO - NCI summarizes changes to the CCSG NOFO